» Articles » PMID: 8178550

Biodegradable Microspheres As Controlled-release Tetanus Toxoid Delivery Systems

Overview
Journal Vaccine
Date 1994 Mar 1
PMID 8178550
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

Purified tetanus toxoid, a high-molecular-weight protein, was entrapped within poly(L-lactic acid) (PLA) and poly(D,L-lactic/glycolic acid) (PLGA) microspheres prepared by either a solvent extraction or a solvent evaporation method carried out in a multiple emulsion system (water-in-oil-in-water). The physical integrity and antigenicity of the protein treated under different processing conditions were investigated. A reduction of antigenicity that was related to the percentage of aggregated protein was noticed under some experimental conditions. This partial loss of antigenicity was associated with the lyophilization process and affected by the nature of the organic solvent. All types of microspheres prepared with different molecular weight PLA and PLGA displayed a high protein-loading efficiency (> 80%) but their size was strongly influenced by polymer molecular weight (3000 versus 100,000). Protein release pattern was influenced by both polymer molecular weight and composition (PLA versus PLGA). A constant release pattern after an induction period of 10 days was observed for microspheres composed of high-molecular-weight polymers (PLA and PLGA). The release rate was lower from PLA microspheres than from PLGA microspheres. In contrast, a continuously increasing release rate preceded by a burst was observed for low-molecular-weight (3000) PLGA microspheres. Microencapsulated tetanus toxoid was significantly more immunogenic in mice than fluid toxoid as determined by IgG anti-tetanus antibody levels and neutralizing antibodies. However, the magnitude and duration of the antibody response did not differ significantly from a similar dose of aluminium phosphate-adsorbed toxoid. We conclude that microencapsulated tetanus toxoid shows significant adjuvant activity.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

Semisynthetic Pneumococcal Glycoconjugate Nanovaccine.

Prasanna M, Varela Calvino R, Lambert A, Arista Romero M, Pujals S, Trottein F Bioconjug Chem. 2023; 34(9):1563-1575.

PMID: 37694903 PMC: 10515484. DOI: 10.1021/acs.bioconjchem.3c00252.


Metal-HisTag coordination for remote loading of very small quantities of biomacromolecules into PLGA microspheres.

Albert J, Chang R, Garcia G, Schwendeman S Bioeng Transl Med. 2022; 7(2):e10272.

PMID: 35600641 PMC: 9115689. DOI: 10.1002/btm2.10272.


Engineered drug delivery devices to address Global Health challenges.

Sadeghi I, Byrne J, Shakur R, Langer R J Control Release. 2021; 331:503-514.

PMID: 33516755 PMC: 7842133. DOI: 10.1016/j.jconrel.2021.01.035.


Interfacial tension effects on the properties of PLGA microparticles.

Otte A, Sharifi F, Park K Colloids Surf B Biointerfaces. 2020; 196:111300.

PMID: 32919245 PMC: 7708423. DOI: 10.1016/j.colsurfb.2020.111300.


Investigating the Effect of Encapsulation Processing Parameters on the Viability of Therapeutic Viruses in Electrospraying.

Sanders 2nd T, Milicic A, Eleanor Stride Pharmaceutics. 2020; 12(4).

PMID: 32344667 PMC: 7238258. DOI: 10.3390/pharmaceutics12040388.